Medical Equipment

Congestive Heart Failure Treatment Devices Market Outlook For 2026–2030 Covering Growth Drivers And Industry Trends

April 10, 2026April 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Congestive Heart Failure Treatment Devices Market Expected To Scale Between 2026 And 2030?

The congestive heart failure treatment devices market has experienced robust expansion in recent years. Its size is anticipated to expand from $21.07 billion in 2025 to $22.76 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.0%. This market’s historical development can be attributed to several factors, including the increasing prevalence of congestive heart failure, a rise in cardiovascular disease incidence, greater adoption of implantable cardiac devices, the establishment of more specialized cardiac care facilities, and improvements in the survival rates of heart failure patients.

The congestive heart failure treatment devices market is projected to experience substantial expansion over the forthcoming years. This market is anticipated to reach $30.07 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. Several factors are expected to drive this growth during the forecast period, including an aging population more susceptible to heart failure, a rising need for minimally invasive cardiac treatments, an intensified emphasis on prompt intervention and managing the disease, broader availability of sophisticated heart failure treatments in developing regions, and the increasing utilization of prolonged mechanical circulatory support devices. Key trends identified for the forecast period encompass a growing acceptance of advanced implantable devices for heart failure, an expanded application of ventricular assist devices in advanced congestive heart failure, a heightened commitment to decreasing hospital admissions due to heart failure, the broadening of device-based solutions for sustained cardiac assistance, and an escalating requirement for ongoing cardiac surveillance and care.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15774&type=smp

What Key Factors Are Affecting The Congestive Heart Failure Treatment Devices Market Demand?

The increasing occurrence of cardiovascular conditions is anticipated to drive expansion in the congestive heart failure treatment devices market. These disorders encompass a range of diseases impacting the heart and blood vessels, including coronary artery disease, hypertension, and heart failure, which affect blood circulation and overall cardiac well-being. The growing incidence of cardiovascular disorders primarily stems from a rise in risk factors such as obesity, inactive lifestyles, unhealthy eating habits, and an aging demographic. Congestive heart failure treatment devices play a vital role in managing cardiovascular conditions by stabilizing heart rhythms and enhancing cardiac performance, thereby notably improving patient outcomes. For instance, reports from October 2024 by the US government’s Centers for Disease Control and Prevention indicated that in 2023, cardiovascular disease was responsible for 919,032 lives, representing one in every three fatalities. Coronary heart disease continued to be the most common type of heart ailment, and it was observed that approximately one in six cardiovascular disease deaths occurred in individuals younger than 65 years. Consequently, the increased prevalence of cardiovascular disorders is fueling the expansion of the congestive heart failure (CHF) treatment devices market.

What Are The Different Segment Types In The Congestive Heart Failure Treatment Devices Market Segment Breakdown?

The congestive heart failure treatment devices market covered in this report is segmented –

1) By Product: Cardiac Pacemaker, Implantable Cardioverter Defibrillators (ICDs), Cardiac Resynchronization Therapy Devices (CRT), Counter Pulsation Devices, Ventricular Assist Devices (VADs)

2) By Application: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)

3) By End-User: Hospitals And Clinic, Specialized Cardiovascular Disease Treatment Centers, Ambulatory Surgery Centers

Subsegments:

1) By Cardiac Pacemaker: Single Chamber Pacemaker, Dual Chamber Pacemaker, Biventricular Pacemaker

2) By Implantable Cardioverter Defibrillators (ICDs): Traditional ICDs, Subcutaneous ICDs, CRT-D (Cardiac Resynchronization Therapy Defibrillator)

3) By Cardiac Resynchronization Therapy Devices (CRT): CRT-P (Cardiac Resynchronization Therapy Pacemaker), CRT-D (Cardiac Resynchronization Therapy Defibrillator)

4) By Counter Pulsation Devices: Intra-Aortic Balloon Pumps (IABP), External Counterpulsation Devices (ECP)

5) By Ventricular Assist Devices (VADs): Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Biventricular Assist Devices (BiVAD)

What Trends Are Influencing Changes In The Congestive Heart Failure Treatment Devices Market?

Major companies operating in the congestive heart failure treatment devices market are focusing on developing innovative solutions, such as the implant-free atrial septostomy system, to enhance hemodynamic relief, reduce procedural complexity, and offer less invasive treatment alternatives for heart failure patients. An implant-free atrial septostomy system refers to a minimally invasive device designed to create a controlled opening in the atrial septum without leaving a permanent implant, enabling improved left atrial pressure reduction and enhanced cardiac hemodynamics in heart failure patients. For instance, in January 2025, Alleviant Medical Inc., a US-based medical device company, received significant FDA milestones for its novel no-implant interatrial shunt device for treating heart failure. It offers a minimally invasive solution for heart failure by creating a precise shunt that reduces elevated pressure in the left atrium without leaving a permanent implant. This approach minimizes complications linked to implanted devices, promotes durable shunt patency, and improves symptoms, exercise capacity, and quality of life for chronic heart failure patients. Its purpose is to unload the heart, alleviate symptoms, and provide a safer, innovative treatment option for patients with limited alternatives.

Who Are The Well-Known Companies In The Congestive Heart Failure Treatment Devices Market?

Major companies operating in the congestive heart failure treatment devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co KG, LivaNova PLC, Berlin Heart GmbH, Jarvik Heart Inc, ReliantHeart Inc, Abiomed Inc, Lepu Medical Technology Co Ltd, Magenta Medical Ltd, MicroPort Inc, EBR Systems Inc, Syncardia Systems LLC, Oscor Inc, OSYPKA Medical GmbH, Calon Cardio-Technology, CoreWave SA, Zoll Medical Corporation

Get The Full Congestive Heart Failure Treatment Devices Market Report:

https://www.thebusinessresearchcompany.com/report/congestive-heart-failure-treatment-devices-global-market-report

Which Region Leads The Congestive Heart Failure Treatment Devices Market In Overall Market Size?

North America was the largest region in the congestive heart failure treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congestive heart failure treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Congestive Heart Failure Treatment Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=15774&type=smp

Browse Through More Reports Similar to the Global Congestive Heart Failure Treatment Devices Market 2026, By The Business Research Company

Heart Defect Closure Device Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

Congestive Heart Failure Treatment Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/congestive-heart-failure-treatment-devices-global-market-report

Structural Heart Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795